FYI more Seeingone of our patients progress from no strength in...

FYI more

Seeingone of our patients progress from no strength in his arm, and no movement inhis fingers and thumb, to playing wheelchair rugby is extremely encouraging forour researchers and clinical partners.

‘Offthe back of these positive interim results, our team is accelerating regulatoryapplications in the US, EU and Australia to make this treatment accessible tothe more than 700,000 people who experience nerve damage annually.’

Therefore,this capital raise may be part of these efforts. Funding that could help withthese applications in some way shape or form.

No doubtinvestors would love to see management commit to a commercialisation bid. Thatcould be the catalyst the stock needs to really take off.

Afterall, one positive announcement is all it takes to set a penny stock like OCC soaring sometimes. They are stocks that live and die on speculation. Which can net savvy traders some serious gains.

If youwant to learn more about penny stocks, then check out our handy report. In itwe cover how this volatile sector operates, and how you could benefit. Get yourcopy right now, right here.

As forOCC, well we’ll have to wait for the details to come to light later this week.